Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time

Biological Psychiatry

Volumn 39, Issue 6, 1996, Pages 444-447

  Papakostas, Yiannis ^a,c   Markianos, Manolis ^a   Pehlivanidis, Artemis ^a   Papadimitriou, George N ^a   Zervas, Iannis M ^a   Daras, Michael ^b   Stefanis, Costas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Depression; Electroconvulsive therapy (ECT); Prolactin (PRL); Seizure duration; Thyrotropin releasing hormone (TRH)

Indexed keywords

PLACEBO; PROLACTIN; PROTIRELIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEIZURE;

EID: 0029866452     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00198-0     Document Type: Article

References (19)

1. Abrams R, Swartz CM (1989): ECT Instruction Manual for the Thymatron DG. Chicago IL: Somatics Inc.
2. Aperia B, Thoren M, Wetterberg L (1985): Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness. Acta Psychiatr Scand 72:302-308.
3. Devanand DP, Sackeim HA, Pierson D, Novacenko H, Prudic J, Ross F (1989): Prolactin response to TRH and ECT; a common mechanism? Biol Psychiatry 205:106 A.
4. Dolva LO, Riddervold F, Thorsen RK (1983): Side effects of thyrotropin releasing hormone. Br Med J 287:532.
5. Griffiths EC (1985): Thyrotropin releasing hormone: Endocrine and central effects. Psychoendocrinology 10:225-235.
6. Ho KY, Smythe GA, Lazarus L (1985): The interaction of TRH and dopaminergic mechanisms in the regulation of stimulated prolactin release in man. Clin Endocrinol 23:7-16.
7. Khan A, Mirolo MH, Claypoole K, Bhang J, Cox G, Horita A, Tucker G (1994): Effects of low-dose TRH on cognitive deficits in the ECT postictal state. Am J Psychiatry 151: 1694-1696.
8. Kubek MJ, Low WC, Sattin A, Marzorati SL, Meyerhoff JL, Larsen SH (1989): Role of TRH in seizure modulation. Ann NY Acad Sci 553:286-303.
9. Lankford HV, Blackard WG, Gardner DF, Tucker HSTG (1981): Effects of thyrotropin-releasing hormone and metoclopramide in patients with phenothiazine-induced hyperprolactinemia. J Clin Endocrinol Metab 53:109-112.
10. Maeda K, Tanimoto K (1981): Epileptic seizures induced by thyrotropin releasing hormone. Lancet 1:1058-1059.
11. Metcalf G (1982): Regulatory peptides as a source of new drugs - the clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res Rev 4:389-408.
12. Ohman R, Balldin J, Walinder J, Wallin L (1976): Prolactin response to electroconvulsive therapy. Lancet 1:936-938.
13. Papakostas Y, Markianos M, Papadimitriou G, Lykouras L, Stefanis C (1991): Thyrotropin and prolactin responses to ECT in schizophrenia and depression. Psychiatry Res 37:5-10.
14. Papakostas Y, Markianos M, Papadimitriou G, Stefanis C (1986): Prolactin response induced by ECT and TRH. Br J Psychiatry 148:721-723.
15. Post RM, Weiss SRB (1992): Endogenous biochemical abnormalities in affective illness: Therapeutic versus pathogenic. Biol Psychiatry 32:469-484.
16. Rojdmark S, Rossner S (1991): Decreased dopaminergic control of prolactin secretion in male obesity: Normalisation by fasting. Metabolism 40:191-195.
17. Swartz CM (1993): Clinical and Laboratory Predictors of ECT Response. In Coffey CE (ed), The Clinical Science of Electroconvulsive Therapy. Washington DC: American Psychiatric Press.
18. Ylikorkala O, Kivinen S, Vinikka L (1981): Regulation of prolactin and thyrotropin secretion during human pregnancy: Effect of sulpiride and TRH administration. Acta Endocrinol 98:451-455.
19. Zis AP, McGarvey KA, Clark CM, Lam RW, Adams SA (1992): The role of dopamine in seizure-induced prolactin release in humans. Convuls Ther 8:126-130.